$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sustained release drug-resin complexes 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/74
  • A61K-009/14
  • A61K-009/52
출원번호 US-0265910 (1988-11-02)
발명자 / 주소
  • Kelleher William J. (Storrs CT) Carpanzano Anthony E. (Sherman CT)
출원인 / 주소
  • Richardson-Vicks, Inc. (Shelton CT 02)
인용정보 피인용 횟수 : 118  인용 특허 : 6

초록

Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subsequently coated with a water-permeable diffusio

대표청구항

An oral pharmaceutical composition in unit dosage form consisting essentially of irregularly shaped ion-exchange resin particles with an ion-exchange capacity of less than about 6 meq/gram having particle sizes ranging from about 10 to about 500 microns, said particles having a pharmacologically act

이 특허에 인용된 특허 (6)

  1. Raghunathan Yegnaswami (Perinton NY), Controlled release pharmaceutical preparations.
  2. Samejima Masayoshi (Minoh JPX) Hirata Goichi (Yawata JPX) Koida Yoshiyuki (Katano JPX) Kida Akira (Settsu JPX), Process for preparing ethylcellulose microcapsules.
  3. Samejima Masayoshi (Minoh JPX) Hirata Goichi (Yawata JPX) Koida Yoshiyuki (Katano JPX), Process for preparing pharmaceutically active compound-containing microcapsules.
  4. Raghunathan Yegnaswami (Fairport NY), Prolonged release pharmaceutical preparations.
  5. Fischer Franz X. (Riehen CHX) Khanna Satish C. (Bottmingen CHX), Resinate sustained release dextromethorphan composition.
  6. Jaquiss Donald B. G. (New Harmony IN) Scott Steven W. (Evansville IN) Vaughn ; Jr. Howard A. (Schenectady NY) Williams Joseph B. (Mt. Vernon IN), Stabilized polycarbonate compositions.

이 특허를 인용한 특허 (118)

  1. Mehta, Ketan; Tu, Yu-Hsing; Chaudhuri, Alivia; Perumal, Ashok, Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings.
  2. Kositprapa, Unchalee; Sriwongjanya, Mongkol, Antihistamine and decongestant system.
  3. Wen Betty,CAX ; Ramsay Michael P.,CAX ; Scheurer Heinrich,CAX ; Dokuzovic Val,CAX ; Lam Vincent,CAX, Antitussive drugs delivered by ion exchange resins.
  4. Mehta, Ketan; Tu, Yu-Hsing, Clonidine formulation.
  5. Matsuda, Kazuko; Iwaki, Yuichi, Combination of ibudilast and riluzole and methods of using same.
  6. Tengler, Mark; McMahen, Russell, Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles.
  7. Tengler, Mark; McMahen, Russell, Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles.
  8. Tengler, Mark; McMahen, Russell, Compositions comprising methylphenidate complexed with ion-exchange resin particles.
  9. Tengler, Mark; McMahen, Russell, Compositions comprising methylphenidate complexed with ion-exchange resin particles.
  10. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  11. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  12. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  13. Oshlack, Benjamin; Huang, Hua Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  14. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  15. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  16. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  17. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  18. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  19. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  20. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  21. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  22. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  23. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  24. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  25. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  26. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  27. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  33. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  39. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  40. Royce Alan E. (Effort PA), Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms.
  41. Guo, Jian-Hwa; Wilber, William Robert, Dosage form of N-acetyl cysteine.
  42. Eichman Martin L., Drug-resin complexes stabilized by chelating agents.
  43. Andres Gruber ; Sharad B. Murdande ; Taehee Kim ; Sinil Kim, Epidural administration of therapeutic compounds with sustained rate of release.
  44. Jaiswal, Sunil Beharilal; Shah, Vaibhavi Ankur; Tiwari, Sunil Deviprasad, Extended release pharmaceutical compositions.
  45. Bess, William S.; Kulkarni, Neema; Ambike, Suhas H.; Ramsay, Michael P., Fast dissolving orally consumable films containing a taste masking agent.
  46. Bess,William S.; Kulkarni,Neema; Ambike,Suhas H.; Ramsay,Michael P., Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1.
  47. Sriwongjanya,Mongkol; Yuk,Samuel; Nangia,Avinash, Formulation and process for drug loaded cores.
  48. Raman, Siva N.; Cunningham, John P., Granular sustained release preparation and production thereof.
  49. Raman, Siva N.; Cunningham, John P., Granular sustained release preparation and production thereof.
  50. Ottoboni Thomas B. ; Jungherr Lisa B. ; Yamamoto Ronald K., Hydrogel-based microsphere drug delivery systems.
  51. Srinivasan, Viswanathan; Brown, Ralph; Brown, David; Patel, Himanshu; Menendez, Juan Carlos; Suphasawud, Somphet Peter, Hyoscyamine dosage form.
  52. Srinivasan, Viswanathan; Brown, Ralph; Brown, David; Patel, Himanshu; Menendez, Juan Carlos; Suphasawud, Somphet Peter, Hyoscyamine dosage form.
  53. Mayer, David J.; Price, Donald D.; Mao, Jianren; Lyle, John W., Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance.
  54. Mayer,David J.; Mao,Jianren, Inhibiting the development of tolerance to and/or dependence on an addictive substance.
  55. Hall, Harlan; Madsen, J. Scott, Ion exchange resin treated to control swelling.
  56. Hall, Harlan; Madsen, J. Scott, Ion exchange resin treated to control swelling.
  57. Hall, Harlan; Madsen, J. Scott, Ion exchange resin treated to control swelling.
  58. Hall, Harlan; Madsen, J. Scott, Ion exchange resin treated to control swelling.
  59. Hall, Harlan; Madsen, J. Scott, Ion exchange resin treated to control swelling.
  60. Tengler, Mark; McMahen, Russell, Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles.
  61. McMahen, Russell; Tengler, Mark; Sloane, Michael; Lockhart, Daniel, Method of formulating and designing liquid drug suspensions containing ion exchange resin particles.
  62. Matsuda, Kazuko; Iwaki, Yuichi, Method of inhibiting or treating fibrosis.
  63. Matsuda, Kazuko, Method of treating liver disorders.
  64. Matsuda, Kazuko, Method of treating non-alcoholic fatty liver disease and steatohepatitis.
  65. Matsuda, Kazuko, Method of treating non-alcoholic steatohepatitis.
  66. Eswara Amruta R. ; Muni Neal ; Schneider F. Howard ; Mione Peter J., Methods and articles of manufacture for nicotine cessation and monitoring nicotine use.
  67. Murphy, John J.; D'Orlando, Kay Jorgenson, Methods and compositions for alleviating stuttering.
  68. Murphy, John J.; D'Orlando, Kay Jorgenson, Methods and compositions for alleviating stuttering.
  69. Murphy, John J.; D'Orlando, Kay Jorgenson, Methods and compositions for alleviating stuttering.
  70. Matsuda, Kazuko, Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels.
  71. McMahen, Russell; Tengler, Mark; Sloane, Michael; Lockhart, Daniel, Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles.
  72. McMahen, Russell; Tengler, Mark; Sloane, Michael; Lockhart, Daniel, Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles.
  73. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  74. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  75. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  76. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  77. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  78. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  79. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  80. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  81. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  82. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  83. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  84. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  85. Venkatesh, Gopi M.; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  86. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  87. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  88. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  89. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  90. Venkatesh, Gopi; Clevenger, James M., Modified release dosage forms of skeletal muscle relaxants.
  91. Venkatesh,Gopi; Clevenger,James M., Modified release dosage forms of skeletal muscle relaxants.
  92. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug - ion exchange resin complexes.
  93. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  94. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  95. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  96. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  97. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  98. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  99. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  100. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  101. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  102. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  103. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  104. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  105. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  106. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug—ion exchange resin complexes.
  107. Saltzman W. Mark ; Colvin O. Michael ; Dang Wenbin ; Ludeman Susan, Multipart drug delivery system.
  108. Kim, Hyoung-Chun, Neuroprotective properties of dextrorotatory morphinans.
  109. Sriwongjanya,Mongkol; Weng,Timothy; Barman,David; Kositprapa,Unchalee, Once a day antihistamine and decongestant formulation.
  110. Muller Walter,DEX ; Cremer Karsten,DEX, Oral administration form having acid active substances and a process for its production.
  111. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  112. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  113. Tengler, Mark; McMahen, Russell, Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles.
  114. Locke,Kenneth Walter; Smith,Charles G.; Kiyoizumi,Takashi, Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis.
  115. Locke, Kenneth Walter; Smith, Charles G.; Kiyoizumi, Takashi, Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis.
  116. Locke, Kenneth Walter; Smith, Charles G.; Kiyoizumi, Takashi, Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome.
  117. Veronesi Paolo Alberto,ITX ; Veronesi Anna Maria,ITX, Programmed release ambroxol--HCl dosage forms.
  118. Kumbhani,Davejibhai; Pandya,Harish B.; Patel,Hiren, Sustained release pharmaceutical preparations and methods for producing the same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로